Literature DB >> 171149

Inhibition of the response of mouse thyroid to tryrotropin induced by chronic triiodothyronine treatment.

M Gafni, N Sirkis, J Gross.   

Abstract

Administration of 1 mU bovine TSH iv to mice resulted, within 1 hour, in the increase of the serum T4 level from 32 +/- 1.4 ng/ml to 53 +/- 2.6 ng/ml (Mean +/- SE, n = 24). Treatment with 1 mug triiodothyronine (T3) per day, for 10 days, abolished the responsiveness of the thyroid to TSH, as measured by thyroxine (T4) release. Thyroidal response to TSH was measured also in vitro. The basal hormonal release was 4.66 +/- 0.55 ng T4 and 0.98 +/- 0.15 ng T3 per thyroid per 3 h (n = 30). In the presence of bovine TSH (0.2 mU/ml) the hormonal secretion increased 3-fold for T4 and 2.5-fold for T3. Thyroids from mice pretreated with T3 for 10 days showed almost no response to TSH. Partial refractoriness to TSH was already significant 5 days after T3 pretreatment. Responsiveness to TSH was restored 3 days after T3 withdrawal or after 3 daily injections of 10 mU bovine TSH, concomitant with the last 3 days of T3 pretreatment. These results indicated that the prolonged absence of an adequate level of trophic hormone may be the cause of thyroidal unresponsiveness to acute TSH treatment. With 20 mU of TSH, cAMP levels rose from 4 +/- 0.5 picomoles to 80 +/- 9.3 picomoles per thyroid (n = 6). In mice subjected to 10 days of T3 pretreatment the response was markedly reduced: 20 +/- 3 picomoles/ thyroid. Thyroids of the T3-treated mice responded normally to 1 mM DBcAMP in vitro. From these results it was concluded that the impaired responsiveness of the thyroids to TSH occurs at a step prior to cAMP accumulation.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 171149     DOI: 10.1210/endo-97-5-1256

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  8 in total

1.  Norepinephrine and TSH: effects on thyroidal radioiodine and thyroxine release.

Authors:  M L Maayan; E M Volpert
Journal:  J Endocrinol Invest       Date:  1989-12       Impact factor: 4.256

Review 2.  Thyroid autoregulation.

Authors:  M A Pisarev
Journal:  J Endocrinol Invest       Date:  1985-10       Impact factor: 4.256

3.  Thyroid hormone inhibition of intermediary metabolism in dog thyroid slices stimulated by different agonists.

Authors:  D Pasquali; A Bellastella; J B Field
Journal:  J Endocrinol Invest       Date:  1991-11       Impact factor: 4.256

4.  An in vitro procedure for the estimation of thyroid hormone releasing factors in sera of thyrotoxic patients.

Authors:  M L Maayan; E M Volpert; F P Dawry
Journal:  J Endocrinol Invest       Date:  1978-10       Impact factor: 4.256

5.  In vitro and in vivo refractoriness to thyrotropin stimulation of iodine organification and thyroid hormone secretion.

Authors:  J B Field; A Dekker; G Titus; M E Kerins; W Worden; R Frumess
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

Review 6.  Biochemistry of thyroid regulation under normal and abnormal conditions.

Authors:  M A Pisarev; D L Kleiman de Pisarev
Journal:  J Endocrinol Invest       Date:  1980 Jul-Sep       Impact factor: 4.256

7.  Thyrotropin-induced increase in phosphoprotamine phosphatase activity in rat thyroid.

Authors:  M Roques; A Tirard
Journal:  J Endocrinol Invest       Date:  1980 Apr-Jun       Impact factor: 4.256

8.  Inhibition of cyclic 3',5' monophosphate synthesis in rat testis by L-triiodothyronine.

Authors:  M M Flawia; A R Kornblihtt; D de Mendoza; H N Torres
Journal:  Mol Cell Biochem       Date:  1981-02-11       Impact factor: 3.396

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.